3 War-on-Cash Stocks to Hold for Years
These companies are already benefiting from this growing trend.
Kimberly-Clark Predicts a Growth Slowdown Ahead
The consumer product giant's results looked weak in comparison to its chief global rival.
Is Abiomed Stock a Buy?
Abiomed had a rough time in 2019, but the growth story hasn’t changed. Recent share declines could be an opportunity to make a great entry point.
Divesting businesses, rather than acquiring them, is a rare occurrence for this executive.
A bad start to the new week stemmed from worries about the outbreak.
The streaming specialist is trading lower this year, but there are a lot of reasons to be hopeful for a turnaround.
Don't throw your money away in the course of getting tax help.
These are some of the safest dividend stocks you can hold.
Vaping-related illnesses continue to be a big problem for the cannabis industry.
Here’s what investors should expect from the January FOMC meeting.
The company's streaming moves position it to grow.
Here's how to really benefit from your retirement savings.
In space, no one can hear you scream "SpaceX is winning!" But it is.
Another unprofitable unicorn is about to make a splash on the market.
Investors are bidding up these biotechs in response to the health threat.
The game maker is seeing explosive growth from in-game spending.
The company had a great 2019 and looks well set for 2020, too.
Solid growth prospects make this animal health company an investor favorite, but don't forget to examine the price you'd pay.
Management warns changing consumer behavior and price hikes will cause even greater video subscriber losses in 2020.
Concept-proving results for lead programs at these biotechs will send their stock prices soaring or sinking before the year's over.
There are some cases where a contribution won't be deductible on your taxes.
Medicare's general enrollment period lets you sign up for coverage if you didn't do so when you first got the chance.
A profitable pot stock with a 5% yield does exist, but it's not without risks.